Moderna’s mRNA-1273 is the third COVID-19 vaccine to be approved for use by the Medicines and Healthcare products Regulatory Agency (MHRA) and is the second mRNA vaccine after Pfizer/BioNTech ...

Much to the consternation of parents, teachers and cruise ship enthusiasts, there are no approved treatments ... furthest along is Moderna, which has developed a norovirus vaccine with the same ...

Moderna has ... version of its COVID-19 vaccine that combines its original version with another targeting the Beta variant, and seems to offer improved protection. The booster shot – called ...

Real-world evidence continues to show that mRNA vaccines and booster doses ... clinical trials. Moderna is developing vaccines against viruses for which there are no approved jabs today, she ...

The side effects of this booster shot are similar to those of the Moderna booster. However, research shows that people who ...

It looked at differences between patients given a Moderna booster after having had two jabs of the Pfizer vaccine and those who received the Pfizer vaccine three times. While about 70 percent of ...

Overall, Moderna said the safety profile is similar to the approved vaccine Spikevax. A detailed analysis of the late-stage ...

including an extensive pipeline of therapeutics in clinical trials that could be the booster shot the stock needs to generate a rebound. Let's discuss the pros and cons of buying Moderna stock.

Now, what about the second booster, which, for people who received Pfizer and Moderna, would be their fourth shot? Who's eligible? Well, right now, you're eligible for a second COVID-19 booster if ...